Clinical Trial Update: A Study of TAK-861 in Participants With Narcolepsy Type 1 [Phase 2]

View source ↗

Summary

TAK-861 was studied in a Phase 2 trial for Narcolepsy Type 1. The study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• TAK-861

Snippet

Sponsor: Takeda | Conditions: Narcolepsy Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2025-01-09